UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.06B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$590M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$368M |
| 4 |
PLAN
Anaplan, Inc.
PLAN
|
+$264M |
| 5 |
UBS Group
UBS
|
+$223M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$717M |
| 2 |
Microsoft
MSFT
|
+$677M |
| 3 |
Apple
AAPL
|
+$653M |
| 4 |
Amazon
AMZN
|
+$641M |
| 5 |
Meta Platforms (Facebook)
META
|
+$351M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.23% |
| 2 | Financials | 6.63% |
| 3 | Healthcare | 5.96% |
| 4 | Consumer Discretionary | 5.78% |
| 5 | Industrials | 4.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MBII
5051
DELISTED
Marrone Bio Innovations, Inc.
MBII
| $455K | ﹤0.01% |
631,518
+598,182
| +1,794% | +$484K |
|
|
GSQD
5052
DELISTED
G Squared Ascend I Inc.
GSQD
| $454K | ﹤0.01% |
45,976
+23,648
| +106% | +$234K |
|
5053
Acco Brands
ACCO
$402M
| $453K | ﹤0.01% |
54,852
+32,919
| +150% | +$284K |
|
5054
Boot Barn
BOOT
$5.11B
| $453K | ﹤0.01% |
3,682
+1,123
| +44% | +$127K |
|
|
TBI
5055
Trueblue
TBI
$323M
| $453K | ﹤0.01% |
16,366
+13,253
| +426% | +$375K |
|
5056
UroGen Pharma
URGN
$2.26B
| $453K | ﹤0.01% |
47,656
+46,345
| +3,535% | +$653K |
|
|
ORAN
5057
DELISTED
Orange
ORAN
| $453K | ﹤0.01% |
42,926
-13,835
| -24% | -$150K |
|
|
TVRD
5058
Tvardi Therapeutics
TVRD
$22M
| $452K | ﹤0.01% |
1,032
+676
| +190% | +$340K |
|
|
DNB
5059
DELISTED
Dun & Bradstreet
DNB
| $451K | ﹤0.01% |
22,006
-168,632
| -88% | -$3.21M |
|
5060
Hingham Institution for Saving
HIFS
$657M
| $451K | ﹤0.01% |
1,074
+718
| +202% | +$271K |
|
5061
Sotera Health
SHC
$5.41B
| $451K | ﹤0.01% |
19,140
-119
| -0.6% | -$2.85K |
|
5062
Dillards
DDS
$9.9B
| $449K | ﹤0.01% |
1,833
-15,111
| -89% | -$3.98M |
|
5063
Brookdale Senior Living
BKD
$3.27B
| $447K | ﹤0.01% |
86,728
+72,153
| +495% | +$450K |
|
|
DCBO
5064
Docebo
DCBO
$594M
| $447K | ﹤0.01% |
6,639
+6,548
| +7,196% | +$471K |
|
5065
Castle Biosciences
CSTL
$988M
| $446K | ﹤0.01% |
10,398
+9,142
| +728% | +$478K |
|
5066
Hanmi Financial
HAFC
$939M
| $446K | ﹤0.01% |
18,844
+6,631
| +54% | +$148K |
|
5067
PAR Technology
PAR
$751M
| $446K | ﹤0.01% |
8,454
+7,032
| +495% | +$424K |
|
|
APPH
5068
DELISTED
AppHarvest, Inc. Common Stock
APPH
| $446K | ﹤0.01% |
114,919
+97,123
| +546% | +$519K |
|
|
GAM
5069
General American Investors Company
GAM
$1.62B
| $445K | ﹤0.01% |
10,057
+845
| +9% | +$37.2K |
|
|
GLU
5070
Gabelli Utility & Income Trust
GLU
$116M
| $445K | ﹤0.01% |
21,162
+462
| +2% | +$9.35K |
|
5071
MaxCyte
MXCT
$130M
| $445K | ﹤0.01% |
43,715
+34,481
| +373% | +$370K |
|
5072
Avita Medical
RCEL
$235M
| $445K | ﹤0.01% |
37,229
+21,042
| +130% | +$321K |
|
|
TEN
5073
DELISTED
Tenneco Inc. Class A Voting Common Stock
TEN
| $445K | ﹤0.01% |
39,354
-1,759
| -4% | -$22K |
|
5074
Columbia Financial
CLBK
$1.12B
| $443K | ﹤0.01% |
21,232
+14,855
| +233% | +$288K |
|
5075
Direxion Daily Homebuilders & Supplies Bull 3X ETF
NAIL
$577M
| $443K | ﹤0.01% |
+3,581
| New | +$344K |
|
Similar funds
UBS Group's Q4 2021 Portfolio in Review
As of Q4 2021, UBS Group held 11,479 positions worth $349B, up 9.9% from $318B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
UBS Group's Q4 2021 filing shows 1,739 new, 5,110 increased, 3,129 reduced and 997 closed positions. Its largest new stake was Hertz: 1,027,564 shares worth $25.7M. The largest sale was iShares Russell 2000 ETF, an estimated $717M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 12% a quarter earlier, followed by Financials and Healthcare.
- UBS Group's largest Q4 2021 buy was Hertz: 1,027,564 shares worth $25.7M.
- UBS Group added most to iShares Core S&P 500 ETF in Q4 2021, an estimated $1.06B increase.
- UBS Group's biggest Q4 2021 reduction was iShares Russell 2000 ETF, cutting an estimated $717M.
- UBS Group fully exited Kansas City Southern in Q4 2021, selling an estimated $81.9M.
- UBS Group's ten largest holdings make up 14% of its $349B portfolio in Q4 2021.
- UBS Group opened 1,739 new positions and closed 997 in Q4 2021.
- UBS Group's portfolio value rose 9.9% quarter-over-quarter to $349B.
Based on UBS Group's 13F filing for Q4 2021, filed 14 Feb 2022.